Resultados globales: 12 registros encontrados en 0.03 segundos.
Artículos, Encontrados 12 registros
Artículos Encontrados 12 registros  1 - 10siguiente  ir al registro:
1.
9 p, 745.8 KB The EMIF-AD Multimodal Biomarker Discovery study : Design, methods and cohort characteristics / Bos, Isabelle (Maastricht University) ; Vos, Stephanie (Maastricht University) ; Vandenberghe, Rik (KU Leuven) ; Scheltens, Philip (Amsterdam UMC. University Medical Center) ; Engelborghs, Sebastiaan (University of Antwerp) ; Frisoni, Giovanni (IRCCS Instituto Centro San Giovanni di Dio Fatebenefratelli) ; Molinuevo, José Luis (Fundació Pasqual Maragall) ; Wallin, Anders (Institute of Neuroscience and Physiology) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Popp, Julius (Lausanne University Hospital) ; Martinez-Lage, Pablo (Centro de Investigación y Tecnología Agroalimentaria de Aragón) ; Baird, Alison (University of Oxford) ; Dobson, Richard (NIHR University College London Hospitals) ; Legido-Quigley, Cristina (King's College London) ; Sleegers, Kristel (University of Antwerp) ; Van Broeckhoven, Christine (University of Antwerp) ; Bertram, Lars (University of Oslo) ; Ten Kate, Mara (Amsterdam UMC. University Medical Center) ; Barkhof, Frederik (Amsterdam UMC. University Medical Center) ; Zetterberg, Henrik (UK Dementia Research Institute) ; Lovestone, Simon (University of Oxford) ; Streffer, Johannes (Janssen Pharmaceutical Companies) ; Visser, Pieter Jelle (Alzheimer Center) ; Universitat Autònoma de Barcelona
There is an urgent need for novel, noninvasive biomarkers to diagnose Alzheimer's disease (AD) in the predementia stages and to predict the rate of decline. Therefore, we set up the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery (EMIF-AD MBD) study. [...]
2018 - 10.1186/s13195-018-0396-5
Alzheimer's research & therapy, Vol. 10 Núm. 1 (june 2018) , p. 64  
2.
6 p, 731.5 KB A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood : Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort / Stamate, Daniel (University of London) ; Kim, Min (Steno Diabetes Center Copenhagen) ; Proitsi, Petroula (King's College London) ; Westwood, Sarah (University of Oxford) ; Baird, Alison (University of Oxford) ; Nevado-Holgado, Alejo (University of Oxford) ; Hye, Abdul (King's College London) ; Bos, Isabelle (Amsterdam UMC) ; Vos, Stephanie J.B. (Maastricht University) ; Vandenberghe, Rik (Amsterdam UMC) ; Teunissen, Charlotte E. (Amsterdam UMC. University Medical Center) ; Kate, Mara Ten (Amsterdam UMC. University Medical Center) ; Scheltens, Philip (Vrije Universiteit Amsterdam) ; Gabel, Silvy (Laboratory for Cognitive Neurology) ; Meersmans, Karen (Laboratory for Cognitive Neurology) ; Blin, Olivier (Aix-Marseille Université) ; Richardson, Jill (GlaxoSmithKline R&D) ; De Roeck, Ellen (University of Antwerp) ; Engelborghs, Sebastiaan (Vrije Universiteit Brussel (VUB)) ; Sleegers, Kristel (Center for Molecular Neurology. VIB) ; Bordet, Régis (University of Lille) ; Ramit, Lorena (Hospital Clínic i Provincial de Barcelona) ; Kettunen, Petronella (Sahlgrenska Academy at University of Gothenburg) ; Tsolaki, Magda (AHEPA University Hospital (Grècia)) ; Verhey, Frans (Maastricht University) ; Alcolea, Daniel (Institut d'Investigació Biomèdica Sant Pau) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Peyratout, Gwendoline (Lausanne University Hospital) ; Tainta, Mikel (Fundacion CITA-alzheimer Fundazioa) ; Johannsen, Peter (Copenhagen University Hospital) ; Freund-Levi, Yvonne (Karolinska Institutet (Estocolm, Suècia)) ; Frölich, Lutz (University of Heidelberg) ; Dobricic, Valerija (University of Lübeck) ; Frisoni, Giovanni B. (IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ; Molinuevo, José L. (Universitat Pompeu Fabra) ; Wallin, Anders (Sahlgrenska Academy at the University of Gothenburg) ; Popp, Julius (Geneva University Hospitals) ; Martinez-Lage, Pablo (Fundación CITA-Alzhéimer Fundazioa) ; Bertram, Lars (University of Oslo) ; Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ; Zetterberg, Henrik (UCL Institute of Neurology (Regne Unit)) ; Streffer, Johannes (University of Antwerp) ; Visser, Pieter J. (Amsterdam UMC) ; Lovestone, Simon (Janssen-Cilag UK Ltd) ; Legido-Quigley, Cristina (King's College London) ; Universitat Autònoma de Barcelona
Machine learning (ML) may harbor the potential to capture the metabolic complexity in Alzheimer Disease (AD). Here we set out to test the performance of metabolites in blood to categorize AD when compared to CSF biomarkers. [...]
2019 - 10.1016/j.trci.2019.11.001
Alzheimer's & dementia, Vol. 5 (2019) , p. 933-938  
3.
11 p, 783.1 KB Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay / Shi, Liu (University of Oxford) ; Westwood, Sarah (University of Oxford) ; Baird, Alison L. (University of Oxford) ; Winchester, Laura (University of Oxford) ; Dobricic, Valerija (University of Lübeck) ; Kilpert, Fabian (University of Lübeck) ; Hong, Shengjun (University of Lübeck) ; Franke, Andre (Christian-Albrechts-University of Kiel) ; Hye, Abdul (King's College London) ; Ashton, Nicholas J. (South London and Maudsley NHS Foundation) ; Morgan, Angharad R. (Cardiff University) ; Bos, Isabelle (Maastricht University) ; Vos, Stephanie J.B. (Amsterdam UMC. University Medical Center) ; Buckley, Noel J (University of Oxford) ; Kate, Mara ten (Amsterdam UMC. University Medical Center) ; Scheltens, Philip (Amsterdam UMC. University Medical Center) ; Vandenberghe, Rik (University Hospitals Leuven (Bèlgica)) ; Gabel, Silvy (Laboratory for Cognitive Neurology) ; Meersmans, Karen (Laboratory for Cognitive Neurology) ; Engelborghs, Sebastiaan (VUB University Hospital Brussels (UZ Brussel)) ; De Roeck, Ellen E. (Institute Born-Bunge. University of Antwerp) ; Sleegers, Kristel (Center for Molecular Neurology. VIB) ; Frisoni, Giovanni B. (IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ; Blin, Olivier (Aix-Marseille Université) ; Richardson, Jill C. (GlaxoSmithKline R&D) ; Bordet, Régis (University of Lille) ; Molinuevo, José L. (Hospital Clínic i Provincial de Barcelona) ; Rami, Lorena (Universitat Pompeu Fabra) ; Wallin, Anders (Sahlgrenska Academy at University of Gothenburg) ; Kettunen, Petronella (University of Oxford) ; Tsolaki, Magda (AHEPA University Hospital (Grècia)) ; Verhey, Frans (Maastricht University) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Alcolea, Daniel (Institut d'Investigació Biomèdica Sant Pau) ; Popp, Julius (Geneva University Hospitals) ; Peyratout, Gwendoline (Lausanne University Hospital) ; Martinez-Lage, Pablo (Fundación CITA-Alzhéimer Fundazioa) ; Tainta, Mikel (CITA-Alzheimer Foundation) ; Johannsen, Peter Copenhagen University Hospital ; Teunissen, Charlotte E. (Vrije Universiteit) ; Freund-Levi, Yvonne (King's College London) ; Frölich, Lutz (University of Heidelberg) ; Legido-Quigley, Cristina (Steno Diabetes Center) ; Barkhof, Frederik (UCL Institutes of Neurology and Healthcare Engineering) ; Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ; Zetterberg, Henrik (UCL Institute of Neurology (Regne Unit)) ; Baker, Susan (Janssen R&D) ; Morgan, B.Paul (Cardiff University) ; Streffer, Johannes (Janssen R&D. LLC) ; Visser, Pieter Jelle (Karolinska Institutet (Estocolm, Suècia)) ; Bertram, Lars (University of Oslo) ; Lovestone, Simon (University of Oxford) ; Nevado-Holgado, Alejo (University of Oxford) ; Universitat Autònoma de Barcelona
Plasma proteins have been widely studied as candidate biomarkers to predict brain amyloid deposition to increase recruitment efficiency in secondary prevention clinical trials for Alzheimer's disease. [...]
2019 - 10.1016/j.jalz.2019.06.4951
Alzheimer's & Dementia, Vol. 15 Núm. 11 (november 2019) , p. 1478-1488  
4.
12 p, 1.1 MB Inflammatory biomarkers in Alzheimer's disease plasma / Morgan, Angharad R. (Systems Immunity Research Institute and UK Dementia Research Institute Cardiff, Cardiff University (Regne Unit)) ; Touchard, Samuel (Systems Immunity Research Institute and UK Dementia Research Institute Cardiff, School of Medicine, Cardiff University (Regne Unit)) ; Leckey, Claire A. (Cardiff University (Regne Unit)) ; O'Hagan, Caroline (Cardiff University (Regne Unit)) ; Nevado-Holgado, Alejo (University of Oxford (Regne Unit)) ; Barkhof, Frederik (University College London) ; Bertram, Lars (Max Planck Institute for Molecular Genetics (Alemanya)) ; Blin, Olivier (Aix-Marseille University (França)) ; Bos, Isabelle (Maastricht University (Països Baixos)) ; Dobricic, Valerija (University of Lübeck (Alemanya)) ; Engelborghs, Sebastiaan (Institute Born-Bunge (Bèlgica)) ; Frisoni, Giovanni B. (IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli (Brescia, Itàlia)) ; Froelich, Lutz (University of Heidelberg (Alemanya)) ; Gabel, Silvy (Laboratory for Cognitive Neurology (Leuven, Bèlgica)) ; Johannsen, Peter (Karolinska Institutet (Stockholm, Sweden)) ; Kettunen, Petronella (University of Gothenburg (Gothenburg, Suècia)) ; Kłoszewska, Iwona (Medical University of Lodz (Lodz, Poland)) ; Legido-Quigley, Cristina (Imperial College London) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Martinez-Lage, Pablo (Fundación CITA-Alzheimer Fundazioa (San Sebastian, Spain)) ; Mecocci, Patrizia (University of Perugia (Itàlia)) ; Meersmans, Karen (Laboratory for Cognitive Neurology (Bèlgica)) ; Molinuevo, José Luis (Universitat Pompeu Fabra) ; Peyratout, Gwendoline (Lausanne University Hospital (Suïssa)) ; Popp, Julius (Hopitaux Universitaires Geneve and Universite de Geneve (Suïssa)) ; Richardson, Jill (GlaxoSmithKline R&D (Regne Unit)) ; Sala, Isabel (Institut d'Investigació Biomèdica Sant Pau) ; Scheltens, Philip (Vrije Universiteit (Països Baixos)) ; Streffer, Johannes (University of Antwerp) ; Soininen, Hikka (University of Eastern Finland) ; Tainta, Mikel (Fundación CITA Alzheimer (Sant Sebastià, País Basc)) ; Teunissen, Charlotte E (University Hospitals Leuven (Bèlgica)) ; Tsolaki, Magda (AHEPA University Hospital (Grècia)) ; Vandenberghe, Rik (Amsterdam University Medical Centers (Països Baixos)) ; Visser, Pieter Jelle (Maastricht University (Països Baixos)) ; Vos, Stephanie (Maastricht University (Països Baixos)) ; Wahlund, Lars Olof (Karolinska Institutet (Estocolm, Suècia)) ; Wallin, Anders (University of Gothenburg Sahlgrenska Academy) ; Westwood, Sarah (University of Oxford (Regne Unit)) ; Zetterberg, Henrik (UK Dementia Research Institute (Londres, Regne Unit)) ; Lovestone, Simon (University of Oxford (Regne Unit)) ; Morgan, B. Paul (Cardiff University (Regne Unit)) ; Bullmore, Edward (University of Cambridge (Regne Unit)) ; Bhatti, Junaid (University of Cambridge (Regne Unit)) ; Chamberlain, Samuel J. (University of Cambridge (Regne Unit)) ; Correia, Marta Morgado (University of Cambridge (Regne Unit)) ; Crofts, Anna L. (Université de Sherbrooke (Canadà)) ; Dickinson, Amber (Addenbroke's Hospital (Cambridge, Regne Unit)) ; Foster, Andy C. (Cambridgeshire and Peterborough NHS Foundation Trust (Regne Unit)) ; Kitzbichler, Manfred G. (University of Cambridge (Regne Unit)) ; Knight, Clare (Cambridgeshire and Peterborough NHS Foundation Trust (Regne Unit)) ; Lynall, Mary-Ellen (University of Cambridge (Regne Unit)) ; Maurice, Christina (University of Cambridge (Regne Unit)) ; O'Donnell, Ciara M. (University College London (Regne Unit)) ; Pointon, Linda J. (University of Cambridge (Regne Unit)) ; St George Hyslop, Peter (University of Cambridge (Regne Unit)) ; Turner, Lorinda (University of Cambridge (Regne Unit)) ; Vertes, Petra E. (University of Cambridge (Regne Unit)) ; Widmer, Barry (University of Cambridge (Regne Unit)) ; Williams, Guy (University of Cambridge (Regne Unit)) ; Cavanagh, Jonathan T. O. (Karolinska Institutet (Suècia)) ; Deith, Catherine (Southern General Hospital Glasgow (Escòcia)) ; Farmer, Scott (Bio Med Sciences Inc.(Galveston, Estats Units)) ; McClean, John (NHS Greater Glasgow and Clyde (Glasgow, Escòcia)) ; McColl, Alison (College of Medical, Veterinary & Life Sciences (Glasgow, Escòcia)) ; McPherson, Andrew (Addenbrooke's Hospital (Cambridge, Regne Unit)) ; Scouller, Paul (Addenbrooke's Hospital (Cambridge, Regne Unit)) ; Sutherland, Murray (NHS Greater Glasgow and Clyde (Glasgow, Escòcia)) ; Boddeke, Erik W.G.M. (Københavns UniversitetThe institution (Copenhaguen, Dinamarca)) ; Khan, Shahid (GlaxoSmithKline plc. (Regne Unit)) ; Murphy, Philip Stephen (GlaxoSmithKline plc. (Regne Unit)) ; Parker, Christine A. (Wellcome Trust (Londres, Regne Unit)) ; Patel, Jai (GlaxoSmithKline plc. (Regne Unit)) ; Jones, Declan (Janssen Pharmaceuticals (Titusville, Estats Units)) ; de Boer, Peter (Janssen Research & Development (Beerse, Bèlgica)) ; Kemp, John A. (KU Leuven- University Hospital Leuven (Bèlgica)) ; Drevets, Wayne Curtis (Janssen Research & Development (Beerse, Bèlgica)) ; Nye, Jeffrey S. (Janssen Research & Development (Beerse, Bèlgica)) ; Wittenberg, Gayle M. (Janssen Research & Development (Beerse, Bèlgica)) ; Isaac, John T.R. (Johnson & Johnson (Estats Units)) ; Bhattacharya, Anindya (Janssen Research & Development (Beerse, Bèlgica)) ; Carruthers, Niicholas L. (Janssen Research & Development (Beerse, Bèlgica)) ; Kolb, Hartmuth Christian (Janssen Research & Development (Beerse, Bèlgica)) ; Pariante, Carmine M. (King's College London (Regne Unit)) ; Turkheimer, Federico (King's College London (Regne Unit)) ; Barker, Gareth John (King's College London (Regne Unit)) ; Byrom, Heidi (King's College London (Regne Unit)) ; Cash, Diana (King's College London (Regne Unit)) ; Cattaneo, Annamaria (King's College London (Regne Unit)) ; Gee, Anthony (King's College London (Regne Unit)) ; Hastings, Caitlín N.M. (King's College London (Regne Unit)) ; Mariani, Nicole (King's College London (Regne Unit)) ; McLaughlin, Anna Patricia (King's College London (Regne Unit)) ; Mondelli, Valeria (King's College London (Regne Unit)) ; Nettis, Maria Antonietta (King's College London (Regne Unit)) ; Nikkheslat, Naghmeh (King's College London (Regne Unit)) ; Randall, Karen (King's College London (Regne Unit)) ; Sheridan, Hannah C. (King's College London (Regne Unit)) ; Simmons, Camilla (King's College London (Regne Unit)) ; Singh, Nisha (King's College London (Regne Unit)) ; Van Loo, Victoria (King's College London (Regne Unit)) ; Vicente-Rodríguez, Marta (King's College London (Regne Unit)) ; Wood, Tobias (King's College London (Regne Unit)) ; Worrell, Courtney (King's College London (Regne Unit)) ; Zajkowska, Zuzanna (King's College London (Regne Unit)) ; Plath, Niels (H. Lundbeck A/S (Copenhagen, Dinamarca)) ; Egebjerg, Jan (H. Lundbeck A/S (Copenhagen, Dinamarca)) ; Eriksson, Hans (H. Lundbeck A/S (Copenhagen, Dinamarca)) ; Gastambide, Francois (H. Lundbeck A/S (Copenhagen, Dinamarca)) ; Adams, Karen Husted (H. Lundbeck A/S (Copenhagen, Dinamarca)) ; Jeggo, Ross D. (H. Lundbeck A/S (Copenhagen, Dinamarca)) ; Thomsen, Christian (Aalborg Universitetshospital (Aalborg, Dinamarca)) ; Pederson, Jan Torleif (H. Lundbeck A/S (Copenhagen, Dinamarca)) ; Campbell, Brian M. (Lundbeck Research USA Inc. (Deerfield, Estats Units)) ; Möller, Thomas (Lundbeck Research USA Inc. (Deerfield, Estats Units)) ; Nelson, Bob (H. Lundbeck A/S (Copenhagen, Dinamarca)) ; Zorn, Stevin H. (Lundbeck Research USA Inc. (Deerfield, Estats Units)) ; O'Connor, Jason (University of Texas Hlth Sci Ctr San Antonio(Estats Units)) ; Attenburrow, Mary Jane (Warneford Hospital. NIHR Oxford Cognit Hlth Clin Res Facil (Oxford, Anglaterra)) ; Baird, Alison (Warneford Hospital. NIHR Oxford Cognit Hlth Clin Res Facil (Oxford, Anglaterra)) ; Benjamin, Jithen (Warneford Hospital. NIHR Oxford Cognit Hlth Clin Res Facil (Oxford, Anglaterra)) ; Clare, Stuart (John Radcliffe Hosp, Oxford Ctr Funct MRI Brain (Oxford, Anglaterra)) ; Cowen, Philip (University of Oxford (Anglaterra)) ; Huang, I-Shuo Wade (Kennedy Inst Rheumatol (Oxford, Anglaterra)) ; Hurley, Samuel A. (University of Wisconsin-Madison (Madison, Estats Units)) ; Jones, Helen (Warneford Hosp, NIHR Oxford Cognit Hlth Clin Res Facil (Oxford, Anglaterra)) ; Mada, Francisca (Neurosciences & Neurology) ; Nevado-Holgado, Alejo (University of Oxford (Anglaterra)) ; Oladejo, Akitayo (Metropolitan Hospital Center (New York, Estats Units)) ; Ribe, Elena (King's College London (Londres, Anglaterra)) ; Smith, Katy (Warneford Hospital. NIHR Oxford Cognit Hlth Clin Res Facil (Oxford, Anglaterra)) ; Vyas, Anviti (University of Oxford (Oxford, Anglaterra)) ; Hughes, Zoe (Praxis Precision Medicines (Cambridge, Regne Unit)) ; Balice-Gordon, Rita (Sanofi S.A. (Gentilly, França)) ; Duerr, James M. (Pfizer Inc.(New York, Estats Units)) ; Piro, Justin R. (Pfizer Inc.(New York, Estats Units)) ; Sporn, Jonathan (Gilgamesh Pharmaceut (New York, Estats Units)) ; Perry, V. Hugh (University of Southampton. Ctr Biol Sci (Hants, Anglaterra)) ; Cleal, Madeleine (University of Portsmouth (Anglaterra)) ; Fryatt, Gemma (University of Southampton. Ctr Biol Sci (Hants, Anglaterra)) ; Gomez-Nicola, Diego (University of Southampton. Ctr Biol Sci (Hants, Anglaterra)) ; Mancuso, Renzo (University of Southampton (Anglaterra)) ; Reynolds, Richard (University of Southampton. Ctr Biol Sci (Hants, Anglaterra)) ; Harrison, Neil (University fo Sussex (Brighton, Anglaterra)) ; Cercignani, Mara (University fo Sussex (Brighton, Anglaterra)) ; Clarke, Charlotte L. (University of Sussex (Brighton, Regne Unit)) ; Hoskins, Elizabeth (Sussex Partnership NHS Foundation Trust (Worthing, Regne Unit)) ; Kohn, Charmaine (Sussex Partnership NHS Foundation Trust (Worthing, Regne Unit)) ; Murray, Rosemary (Addenbrooke's Hospital (Cambridge, Regne Unit)) ; Wilcock, Lauren (Sussex Partnership NHS Fdn Trust (Hove, Anglaterra)) ; Wlazly, Dominika (Brighton and Sussex University Hospitals NHS Trust (Sussex, Anglaterra)) ; Mount, Howard T.J. (University of Toronto (Toronto, Canadà)) ; Universitat Autònoma de Barcelona
Plasma biomarkers for Alzheimer's disease (AD) diagnosis/stratification are a "Holy Grail" of AD research and intensively sought; however, there are no well-established plasma markers. A hypothesis-led plasma biomarker search was conducted in the context of international multicenter studies. [...]
2019 - 10.1016/j.jalz.2019.03.007
Alzheimer's & Dementia, Vol. 15 Núm. 6 (june 2019) , p. 776-787  
5.
12 p, 1.3 MB Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset / Hong, S. (University of Lübeck) ; Prokopenko, D. (Massachusetts General Hospital) ; Dobricic, V. (University of Lübeck) ; Kilpert, F. (University of Lübeck) ; Bos, I. (Vrije Universiteit Amsterdam) ; Vos, S.J.B. (Maastricht University) ; Tijms, Betty M (Vrije Universiteit Amsterdam) ; Andreasson, Ulf (Sahlgrenska University Hospital (Suècia)) ; Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ; Vandenberghe, R. (University Hospitals Leuven (Bèlgica)) ; Cleynen, I. (KU Leuven) ; Gabel, Silvy (KU Leuven) ; Schaeverbeke, J. (KU Leuven) ; Scheltens, Philip (Vrije Universiteit Amsterdam) ; Teunissen, C.E. (Vrije Universiteit) ; Niemantsverdriet, E. (University of Antwerp) ; Engelborghs, Sebastiaan (UZ Brussel and Vrije Universiteit Brussel (VUB)) ; Frisoni, Giovanni B. (IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ; Blin, Olivier (Aix-Marseille Université) ; Richardson, J.C. (GlaxoSmithKline R&D) ; Bordet, Régis (University of Lille) ; Molinuevo, José Luis (Hospital Clínic i Provincial de Barcelona) ; Rami Gonzalez, Lorena (Hospital Clínic i Provincial de Barcelona) ; Kettunen, P. (University of Oxford) ; Wallin, Anders (University of Gothenburg) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Sala, Isabel (Institut d'Investigació Biomèdica Sant Pau) ; Popp, J. (Lausanne University Hospital) ; Peyratout, G. (Lausanne University Hospital) ; Martinez-Lage, P. (CITA-Alzheimer Foundation) ; Tainta, M. (CITA-Alzheimer Foundation) ; Dobson, R.J.B. (University College London) ; Legido-Quigley, Cristina (King's College London) ; Sleegers, K. (University of Antwerp) ; Van Broeckhoven, C. (University of Antwerp) ; ten Kate, M. (Amsterdam Neuroscience) ; Barkhof, Frederik (University College London) ; Zetterberg, H. (UK Dementia Research Institute) ; Lovestone, S. (University of Oxford) ; Streffer, J. (UCB Biopharma SPRL) ; Wittig, M. (Christian-Albrechts-University of Kiel) ; Franke, Andre (Christian-Albrechts-University of Kiel) ; Tanzi, R.E. (Massachusetts General Hospital) ; Visser, Pieter Jelle (Vrije Universiteit Amsterdam) ; Bertram, Lars (University of Oslo) ; Universitat Autònoma de Barcelona
Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder and the most common form of dementia in the elderly. Susceptibility to AD is considerably determined by genetic factors which hitherto were primarily identified using case-control designs. [...]
2020 - 10.1038/s41398-020-01074-z
Translational psychiatry, Vol. 10 Núm. 1 (december 2020) , p. 403  
6.
14 p, 3.0 MB Genome-Wide Association Study of Alzheimer's Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery Dataset / Homann, Jan (Lübeck Interdisciplinary Platform for Genome Analytics. University of Lübeck) ; Osburg, Tim (Lübeck Interdisciplinary Platform for Genome Analytics. University of Lübeck) ; Ohlei, Olena (Lübeck Interdisciplinary Platform for Genome Analytics. University of Lübeck) ; Dobricic, Valerija (Lübeck Interdisciplinary Platform for Genome Analytics. University of Lübeck) ; Deecke, Laura (Lübeck Interdisciplinary Platform for Genome Analytics. University of Lübeck) ; Bos, Isabelle (Vrije Universiteit Amsterdam) ; Vandenberghe, Rik (Neurology Service. University Hospital Leuven) ; Gabel, Silvy (Laboratory for Cognitive Neurology. Department of Neurosciences. KU Leuven) ; Scheltens, Philip (Vrije Universiteit Amsterdam) ; Teunissen, Charlotte E. (Vrije Universiteit Amsterdam) ; Engelborghs, Sebastiaan (Vrije Universiteit Amsterdam) ; Frisoni, Giovanni B. (IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ; Blin, Olivier (Institut Neurosciences Timone. AIX Marseille University) ; Richardson, Jill C. (Neurosciences Therapeutic Area. GlaxoSmithKline RD) ; Bordet, Régis (Lille Neuroscience and Cognition. University of Lille. Inserm. CHU Lille) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Alcolea, Daniel (Institut d'Investigació Biomèdica Sant Pau) ; Popp, Julius (Old Age Psychiatry. Department of Psychiatry. University Hospital of Lausanne) ; Clark, Christopher (Department of Geriatric Psychiatry. University Hospital of Psychiatry Zurich) ; Peyratout, Gwendoline (Old Age Psychiatry. Department of Psychiatry. University Hospital of Lausanne) ; Martinez-Lage, Pablo (Department of Neurology. Center for Research and Advanced Therapies. CITA-Alzheimer Foundation) ; Tainta, Mikel (Department of Neurology. Center for Research and Advanced Therapies. CITA-Alzheimer Foundation) ; Dobson, Richard J.B. (NIHR Biomedical Research Centre at University College London Hospitals NHS Foundation Trust) ; Legido-Quigley, Cristina (King's College London. Institute of Pharmaceutical Sciences) ; Sleegers, Kristel (Center for Molecular Neurology) ; Van Broeckhoven, Christine (University of Antwerp) ; Wittig, Michael (Christian-Albrechts-University of Kiel. Institute of Clinical Molecular Biology) ; Franke, Andre (Christian-Albrechts-University of Kiel. Institute of Clinical Molecular Biology) ; Lill, Christina M. (Ageing Epidemiology Research Unit. School of Public Health. Imperial College London) ; Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ; Zetterberg, Henrik (University College London. UK Dementia Research Institute) ; Lovestone, Simon (University of Oxford. Department of Psychiatry) ; Streffer, Johannes ; ten Kate, Mara (Amsterdam UMC. University Medical Center) ; Vos, Stephanie J.B. (Maastricht University) ; Barkhof, Frederik (University College London) ; Visser, Pieter Jeller (Karolinska Institutet. Department of Neurobiology) ; Bertram, Lars (University of Oslo)
Alzheimer's disease (AD) is the most frequent neurodegenerative disease with an increasing prevalence in industrialized, aging populations. AD susceptibility has an established genetic basis which has been the focus of a large number of genome-wide association studies (GWAS) published over the last decade. [...]
2022 - 10.3389/fnagi.2022.840651
Frontiers in aging neuroscience, Vol. 14 (March 2022) , p. 840651  
7.
8 p, 1.7 MB Plasma Proteomic Biomarkers Relating to Alzheimer's Disease : A Meta-Analysis Based on Our Own Studies / Shi, L. (Department of Psychiatry. University of Oxford) ; Buckley, Noel J (Department of Psychiatry. University of Oxford) ; Bos, Isabelle (Alzheimer Center. VU University Medical Center) ; Engelborghs, Sebastiaan (Department of Neurology. Universitair Ziekenhuis Brussel. Center for Neurociences (C4N). Vrije Universiteit Brussel) ; Sleegers, Kristel (Institute Born-Bunge. Department of Biomedical Sciences. University of Antwerp) ; Frisoni, Giovanni B. (University of Geneva. Department of Psychiatry) ; Wallin, Anders (Institute of Neuroscience and Physiology. Department of Psychiatry and Neurochemistry. The Sahlgrenska Academy at the University of Gothenburg) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Popp, J. (Geriatric Psychiatry. Department of Mental Health and Psychiatry. Geneva University Hospitals) ; Martinez-Lage, P. (CITA-Alzheimer Foundation) ; Legido-Quigley, Cristina (The Systems Medicine Group. Steno Diabetes Center) ; Barkhof, Frederik (UCL Institutes of Neurology and Healthcare Engineering) ; Zetterberg, Henrik (Department of Neurodegenerative Disease. UCL Institute of Neurology) ; Visser, P.J. (Alzheimer Center. VU University Medical Center) ; Bertram, Lars (Department of Psychology. University of Oslo) ; Lovestone, S. ; Nevado-Holgado, Alejo (Department of Psychiatry. University of Oxford)
Background and Objective: Plasma biomarkers for the diagnosis and stratification of Alzheimer's disease (AD) are intensively sought. However, no plasma markers are well established so far for AD diagnosis. [...]
2021 - 10.3389/fnagi.2021.712545
Frontiers in aging neuroscience, Vol. 13 (July 2021) , p. 712545  
8.
13 p, 1.8 MB Replication study of plasma proteins relating to Alzheimer's pathology / Shi, Liu (University of Oxford. Department of Psychiatry) ; Winchester, Laura M. (University of Oxford. Department of Psychiatry) ; Westwood, Sarah (University of Oxford. Department of Psychiatry) ; Baird, Alison L (University of Oxford. Department of Psychiatry) ; Anand, Sneha N (University of Oxford. Department of Psychiatry) ; Buckley, Noel J. (University of Oxford. Department of Psychiatry) ; Hye, Abdul (Maurice Wohl Clinical Neuroscience. Institute of Psychiatry. Psychology and Neuroscience. Kings College London) ; Ashton, Nicholas J. (University of Gothenburg) ; Bos, Isabelle (Alzheimer Center. VU University Medical Center) ; Vos, Stephanie J.B. (Maastricht University. School for Mental Health and Neuroscience) ; Kate, Mara Ten (Amsterdam UMC. University Medical Center) ; Scheltens, Philip (Amsterdam UMC. University Medical Center) ; Teunissen, Charlotte E. (Amsterdam University Medical Centers (AUMC)) ; Vandenberghe, Rik (University Hospitals Leuven (Bèlgica)) ; Gabel, Silvy (KU Leuven. Laboratory for Cognitive Neurology) ; Meersmans, Karen (KU Leuven. Laboratory for Cognitive Neurology) ; Engelborghs, Sebastiaan (Department of Neurology. UZ Brussel and Center for Neurociences (C4N). Vrije Universiteit Brussel) ; De Roeck, Ellen E (Department of Neurology and Memory Clinic. Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken) ; Sleegers, Kristel (University of Antwerp. Institute Born-Bunge) ; Frisoni, Giovanni B. (IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ; Blin, Olivier (AIX marseille university. INS. Ap-hm) ; Richardson, Jill C. (Neurosciences Therapeutic Area. GlaxoSmithKline R&D) ; Bordet, Régis (Inserm. University of Lille. CHU Lille) ; Molinuevo, José L. (Barcelonaβeta Brain Research Center (BBRC)) ; Rami Gonzalez, Lorena (Barcelonaβeta Brain Research Center (BBRC)) ; Wallin, Anders (Institute of Neuroscience and Physiology. Sahlgrenska Academy at University of Gothenburg) ; Kettunen, Petronella (Institute of Neuroscience and Physiology. Sahlgrenska Academy at University of Gothenburg) ; Tsolaki, Magda (AHEPA University Hospital (Grècia)) ; Verhey, Frans (Maastricht University. School for Mental Health and Neuroscience) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Sala, Isabel (Institut d'Investigació Biomèdica Sant Pau) ; Popp, Julius (Geriatric Psychiatry. Department of Mental Health and Psychiatry. Geneva University Hospitals) ; Peyratout, Gwendoline (Lausanne University Hospital) ; Martinez-Lage, Pablo (CITA-Alzheimer Foundation) ; Tainta, Mikel (CITA-Alzheimer Foundation) ; Johannsen, Peter (Danish Dementia Research Centre. Rigshospitalet. Copenhagen University Hospital) ; Freund-Levi, Yvonne (Karolinska Institutet Center for Alzheimer Research. Division of Clinical Geriatrics. School of Medical Sciences Örebro University and Department of Neurobiology. Caring Sciences and Society (NVS)) ; Frölich, Lutz (Department of Geriatric Psychiatry. Zentralinstitut für Seelische Gesundheit. University of Heidelberg) ; Dobricic, Valerija (Lübeck Interdisciplinary Platform for Genome Analytics. Institutes of Neurogenetics and Cardiogenetics. University of Lübeck) ; Legido-Quigley, Cristina (The Systems Medicine Group. Steno Diabetes Center) ; Barkhof, Frederik (UCL Institutes of Neurology and Healthcare Engineering) ; Andreasson, Ulf (Clinical Sahlgrenska University Hospital) ; Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ; Zetterberg, Henrik (UCL Institute of Neurology (Regne Unit)) ; Streffer, Johannes (UCB. Braine-l'Alleud. Belgium. formerly Janssen R&D. LLC Beerse) ; Lill, Christina M. (Ageing Epidemiology Research Unit. School of Public Health. Imperial College) ; Bertram, Lars (Department of Psychology. University of Oslo) ; Visser, Pieter Jelle (Alzheimer Center. VU University Medical Center) ; Kolb, Hartmuth C. (Janssen R&D) ; Narayan, Vaibhav A. (Janssen R&D) ; Lovestone, Simon (Janssen R&D) ; Nevado-Holgado, Alejo (Department of Psychiatry. University of Oxford)
Introduction: This study sought to discover and replicate plasma proteomic biomarkers relating to Alzheimer's disease (AD) including both the "ATN" (amyloid/tau/neurodegeneration) diagnostic framework and clinical diagnosis. [...]
2021 - 10.1002/alz.12322
Alzheimer's & Dementia, Vol. 17 Núm. 9 (september 2021) , p. 1452-1464  
9.
13 p, 2.5 MB TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels / Hong, Shengjun (Lübeck Interdisciplinary Platform for Genome Analytics (LIGA). University of Lübeck) ; Dobricic, Valerija (Lübeck Interdisciplinary Platform for Genome Analytics (LIGA). University of Lübeck) ; Ohlei, Olena (Lübeck Interdisciplinary Platform for Genome Analytics (LIGA). University of Lübeck) ; Bos, Isabelle (Alzheimer Center Amsterdam. Department of Neurology. Amsterdam Neuroscience. Vrije Universiteit Amsterdam) ; Vos, Stephanie J.B. (Alzheimer Center Amsterdam. Department of Neurology. Amsterdam Neuroscience. Vrije Universiteit Amsterdam) ; Prokopenko, Dimitry (Massachusetts General Hospital (Boston)) ; Tijms, Betty M. (Vrije Universiteit Amsterdam) ; Andreasson, Ulf (Sahlgrenska University Hospital (Suècia)) ; Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ; Vandenberghe, Rik (University Hospitals Leuven (Bèlgica)) ; Gabel, Silvy (KU Leuven. Department of Neurosciences) ; Scheltens, Philip (Vrije Universiteit Amsterdam) ; Teunissen, Charlotte E. (Amsterdam University Medical Centers (AUMC)) ; Engelborghs, Sebastiaan (Vrije Universiteit Brussel) ; Frisoni, Giovanni B. (IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ; Blin, Olivier (AIX Marseille University. INS. Ap-hm) ; Richardson, Jill C. (Neurosciences Therapeutic Area. GlaxoSmithKline R&D) ; Bordet, Régis (Inserm. CHU Lille. University of Lille) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Alcolea, Daniel (Institut d'Investigació Biomèdica Sant Pau) ; Popp, Julius (Lausanne University Hospital) ; Clark, Christopher (University Hospital of Psychiatry Zurich) ; Peyratout, Gwendoline (University Hospital of Lausanne. Department of Psychiatry) ; Martinez-Lage, Pablo (Department of Neurology. Center for Research and Advanced Therapies. CITA-Alzheimer Foundation) ; Tainta, Mikel (Department of Neurology. Center for Research and Advanced Therapies. CITA-Alzheimer Foundation) ; Dobson, Richard J.B. (University College London. Hospitals Biomedical Research Centre) ; Legido-Quigley, Cristina (King's College London) ; Sleegers, Kristel (University of Antwerp. Institute Born-Bunge) ; Van Broeckhoven, Christine (University of Antwerp) ; Tanzi, Rudolph E. (Genetics and Aging Unit and McCance Center for Brain Health. Department of Neurology. Massachusetts General Hospital) ; ten Kate, Mara (Amsterdam UMC. University Medical Center) ; Wittig, Michael (Christian-Albrechts-University of Kiel. Institute of Clinical Molecular Biology) ; Franke, Andre (Christian-Albrechts-University of Kiel. Institute of Clinical Molecular Biology) ; Lill, Christina M. (Imperial College. School of Public Health) ; Barkhof, Frederik (University College London. Institutes of Neurology and Healthcare Engineering) ; Lovestone, Simon (University of Oxford. Department of Psychiatry) ; Streffer, Johannes (Translational Medicine Neuroscience. UCB Biopharma SPRL. Braine l'Alleud) ; Zetterberg, Henrik (UCL Institute of Neurology (Regne Unit). UK Dementia Research Institute) ; Visser, Pieter J. (Karolinska Instutet. Department of Neurobiology) ; Bertram, Lars (University of Oslo. Department of Psychology)
Introduction: Neurofilament light (NfL), chitinase-3-like protein 1 (YKL-40), and neurogranin (Ng) are biomarkers for Alzheimer's disease (AD) to monitor axonal damage, astroglial activation, and synaptic degeneration, respectively. [...]
2021 - 10.1002/alz.12330
Alzheimer's & Dementia, Vol. 17 Núm. 10 (october 2021) , p. 1628-1640  
10.
15 p, 2.1 MB Sex-specific metabolic pathways were associated with alzheimer's disease (Ad) endophenotypes in the european medical information framework for ad multimodal biomarker discovery cohort / Xu, J. (King's College London) ; Green, R. (King's College London) ; Kim, M. (Steno Diabetes Center) ; Lord, J. (King's College London) ; Ebshiana, A. (King's College London) ; Westwood, S. (Department of Psychiatry. University of Oxford) ; Baird, Alison L (Department of Psychiatry. University of Oxford) ; Nevado-Holgado, Alejo (Department of Psychiatry. University of Oxford) ; Shi, L. (Department of Psychiatry. University of Oxford) ; Hye, Abdul (King's College London) ; Snowden, S. G. (King's College London) ; Bos, Isabelle (Amsterdam UMC. University Medical Center) ; Vos, S. J. B. (Maastricht University) ; Vandenberghe, R. (Alzheimer Center. VU University Medical Center) ; Teunissen, C. E. (Department of Radiology and Nuclear Medicine. VU University Medical Center) ; Kate, M. T. (Department of Radiology and Nuclear Medicine. VU University Medical Center) ; Scheltens, P. (Alzheimer Center. VU University Medical Center) ; Gabel, Silvy (University Hospitals Leuven (Bèlgica)) ; Meersmans, K. (University Hospitals Leuven (Bèlgica)) ; Blin, Olivier (Clinical Pharmacology & Pharmacovigilance Department. Aix-Marseille University-CNRS) ; Richardson, J. (Neurosciences Therapeutic Area. GlaxoSmithKline R&D) ; De Roeck, Ellen E (University of Antwerp. Institute Born-Bunge) ; Engelborghs, Sebastiaan (RUniversity of Antwerp. Institute Born-Bunge) ; Sleegers, Kristel (Complex Genetics of Alzheimer's Disease Group. VIB Center for Molecular Neurology. VIB) ; Bordet, Régis (Université de Lille. Department of Medical Pharmacology) ; Rami Gonzalez, Lorena (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Kettunen, Petronella (University of Gothenburg) ; Tsolaki, Magda (AHEPA University Hospital (Grècia)) ; Verhey, F. R. J. (Maastricht University. Alzheimer Centrum Limburg) ; Alcolea, Daniel (Institut d'Investigació Biomèdica Sant Pau) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Peyratout, G. (Lausanne University Hospital) ; Tainta, Mikel (Fundación CITA-Alzhéimer Fundazioa) ; Johannsen, Peter (Danish Dementia Research Centre. Rigshospitalet) ; Freund-Levi, Yvonne (King's College London) ; Frölich, L. (University of Heidelberg. Department of Geriatric Psychiatry) ; Dobricic, Valerija (University of Lübeck. Institutes of Neurogenetics and Cardiogenetics) ; Frisoni, Giovanni B. (IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ; Molinuevo, J. L. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Wallin, Anders (University of Gothenburg. Sahlgrenska Academy) ; Popp, J. (University Hospital of Psychiatry Zürich) ; Martinez-Lage, P. (Center for Research and Advanced Therapies. CITA-Alzheimer Foundation) ; Bertram, Lars (University of Oslo. Department of Psychology) ; Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ; Zetterberg, Henrik (UCL Institute of Neurology (Regne Unit)) ; Streffer, J. (Reference Center for Biological Markers of Dementia (BIODEM). Institute Born-Bunge. University of Antwerp) ; Jelle Visser, P. (Maastricht University. Alzheimer Centrum Limburg) ; Lovestone, Simon (Janssen-Cilag UK Ltd.) ; Proitsi, P. (King's College London) ; Legido-Quigley, Cristina (Steno Diabetes Center) ; Universitat Autònoma de Barcelona
Background: physiological differences between males and females could contribute to the development of Alzheimer's Disease (AD). Here, we examined metabolic pathways that may lead to precision medicine initiatives. [...]
2021 - 10.3390/biomedicines9111610
Biomedicines, Vol. 9 Núm. 11 (november 2021) , p. 1610  

Artículos : Encontrados 12 registros   1 - 10siguiente  ir al registro:
Vea también: autores con nombres similares
4 Legido-Quigley, C.
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.